Badreddin Edris - 03 Jun 2024 Form 4 Insider Report for SpringWorks Therapeutics, Inc. (SWTX)

Signature
/s/ Francis I. Perier, Jr. as Attorney-in Fact
Issuer symbol
SWTX
Transactions as of
03 Jun 2024
Net transactions value
-$801,372
Form type
4
Filing time
05 Jun 2024, 16:07:38 UTC
Previous filing
08 Jan 2024
Next filing
12 Jun 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SWTX Common Stock Sale $463,834 -11,772 -4.4% $39.40 257,828 03 Jun 2024 Direct F1, F2
transaction SWTX Common Stock Sale $170,287 -4,192 -1.6% $40.62 253,636 03 Jun 2024 Direct F1, F3
transaction SWTX Common Stock Sale $151,066 -3,651 -1.4% $41.38 249,985 03 Jun 2024 Direct F1, F4
transaction SWTX Common Stock Sale $16,184 -385 -0.15% $42.04 249,600 03 Jun 2024 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a trading plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, adopted on February 29, 2024.
F2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.98 to $39.96. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F3 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.98 to $40.95. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F4 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.98 to $41.955. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F5 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.99 to $42.065. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.